{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:25:25Z","timestamp":1761708325117},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.cancergencyto.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T09:53:50Z","timestamp":1236160430000},"page":"33-39","source":"Crossref","is-referenced-by-count":22,"title":["Frequency of 5\u2032IGH deletions in B-cell chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"190","author":[{"given":"Fabiola","family":"Quintero-Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Nooraie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Nagesh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.12.004_bib1","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours","year":"2001"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(90)90079-P","article-title":"Chromosome aberrations in B-cell chronic lymphocytic leukemia: pathogenetic and clinical implications","volume":"45","author":"Juliusson","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2141.2003.04265.x","article-title":"Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia","volume":"121","author":"Dewald","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.hoc.2004.04.003","article-title":"Molecular genetics and its clinical relevance","volume":"18","author":"Stilgenbauer","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cancergencyto.2004.08.012","article-title":"The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia","volume":"158","author":"Glassman","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.leu.2402528","article-title":"The configuration of immunoglobulin genes in B cell chronic lymphocytic leukemia","volume":"16","author":"Dyer","year":"2002","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.cancergencyto.2008.12.004_bib9","article-title":"Array-based comparative genomic hybridization identifies deletion. Array-based comparative genomic hybridization identifies deletion at 14q32 as a new prognostic marker in chronic lymphocytic leukemia (CLL)","volume":"102","author":"Drandi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.leukres.2004.07.012","article-title":"Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia","volume":"29","author":"Fink","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2353\/jmoldx.2007.060088","article-title":"Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events","volume":"9","author":"Wlodarska","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood.V99.6.2262","article-title":"Somatically mutated IgVH3-21 genes characterize a new subset of chronic lymphocytic leukemia","volume":"99","author":"Tobin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2005-06-2227","article-title":"Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status","volume":"107","author":"Thors\u00e9lius","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.leukres.2005.11.019","article-title":"Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL)","volume":"30","author":"Capello","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1172\/JCI32625","article-title":"Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients","volume":"118","author":"Tschumper","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib16","series-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005)","year":"2005"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib17","unstructured":"Gentleman R, Ihaka R, et\u00a0al. R software environment, version 2.7.2. University of Auckland, New Zealand. (1997). Available at: http:\/\/www.r-project.org\/."},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I","article-title":"Clinical significance of Y chromosome loss in hematologic disease","volume":"27","author":"Wiktor","year":"2000","journal-title":"Genes Chromosomes and Cancer"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10245330400020470","article-title":"CD38 as a prognostic marker in CLL","volume":"10","author":"Matrai","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood-2006-01-013003","article-title":"In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia","volume":"108","author":"Deaglio","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/asheducation-2006.1.279","article-title":"New prognostic markers in CLL","volume":"2006","author":"Monteserrat","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10428190410001680546","article-title":"Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"45","author":"Aoun","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1073\/pnas.0304717101","article-title":"Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations","volume":"101","author":"Schwaenen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ajh.21145","article-title":"Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia","volume":"83","author":"Patel","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Kr\u00f6ber","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V100.2.635","article-title":"Monoclonal B lymphocytes with the characteristics of \u201cindolent\u201d chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.2006.08.3089","article-title":"Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997","volume":"25","author":"Grever","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0167-5699(94)90009-4","article-title":"The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire","volume":"15","author":"Schroeder","year":"1994","journal-title":"Immunol Today"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016546080800705X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016546080800705X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:49:53Z","timestamp":1589618993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016546080800705X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S016546080800705X"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.12.004","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}